1. Home
  2. AISP vs SAVA Comparison

AISP vs SAVA Comparison

Compare AISP & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$3.71

Market Cap

145.9M

Sector

Finance

ML Signal

HOLD

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$3.19

Market Cap

157.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
SAVA
Founded
2006
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.9M
157.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AISP
SAVA
Price
$3.71
$3.19
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
934.4K
1.1M
Earning Date
11-17-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,033,886.00
N/A
Revenue This Year
$34.52
N/A
Revenue Next Year
$59.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$1.15
52 Week High
$7.66
$4.98

Technical Indicators

Market Signals
Indicator
AISP
SAVA
Relative Strength Index (RSI) 46.40 52.27
Support Level $3.51 $2.88
Resistance Level $3.92 $3.45
Average True Range (ATR) 0.28 0.22
MACD 0.11 0.05
Stochastic Oscillator 78.92 72.19

Price Performance

Historical Comparison
AISP
SAVA

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: